Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants

<p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agon...

Full description

Bibliographic Details
Main Author: Lynn, G
Other Authors: Seymour, L
Format: Thesis
Language:English
Published: 2014
Subjects:
_version_ 1826290720051298304
author Lynn, G
author2 Seymour, L
author_facet Seymour, L
Lynn, G
author_sort Lynn, G
collection OXFORD
description <p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agonists (TLR-7/8a). However, poor pharmacokinetic properties have precluded TLR-7/8a for use in vaccines.</p> <p>In this thesis, polymer carriers were used to control pharmacokinetics and to modulate activity of TLR-7/8a for use as vaccine adjuvants. Combinatorial synthesis and <em>in vivo</em> structure-activity studies were used to evaluate how properties of Polymer-TLR-7/8a conjugates (Poly-7/8a) influence innate immune activation in lymph nodes that drain the site of vaccine administration. The most striking finding was that particle formation by Poly-7/8a strongly enhances the magnitude and duration (&gt;14 days) of innate immune activation in lymph nodes by restricting agonist biodistribution and promoting uptake by dendritic cells. Particle-forming Poly-7/8a optimized for activity were found to induce only local innate immune activation (not systemic) and were effective for eliciting Th1-type CD4 and CD8 T cells that mediated protection against infectious challenge. Based on the importance of particle formation for activity of Poly-7/8a, thermo-responsive Poly-7/8a were developed that exist as single water-soluble macromolecules in solution but undergo temperature-driven particle formation <em>in vivo</em>. In conclusion, polymer carriers of TLR-7/8a represent a versatile and effective platform for modulating innate immune activity and warrant further investigation as a class of adjuvants for vaccines.</p>
first_indexed 2024-03-07T02:48:30Z
format Thesis
id oxford-uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e49
institution University of Oxford
language English
last_indexed 2024-03-07T02:48:30Z
publishDate 2014
record_format dspace
spelling oxford-uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e492022-03-27T03:31:41ZPolymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvantsThesishttp://purl.org/coar/resource_type/c_db06uuid:acdb09f7-e690-4cf2-b0e4-3b1611750e49VaccinologyAdvanced materialsChemistry & allied sciencesPolymers Amino acid and peptide chemistryChemical biologyMaterials SciencesSupramolecular chemistryImmunologyNano-biotechnologyNanomaterialsEnglishOxford University Research Archive - Valet2014Lynn, GSeymour, L<p>There is currently a need for vaccine adjuvants that are effective for eliciting Th1-type CD4 and CD8 T cell responses when formulated with protein and peptide-based subunit vaccines. Some of the most promising adjuvants in this regard are combined small molecule Toll-like receptor-7/8 agonists (TLR-7/8a). However, poor pharmacokinetic properties have precluded TLR-7/8a for use in vaccines.</p> <p>In this thesis, polymer carriers were used to control pharmacokinetics and to modulate activity of TLR-7/8a for use as vaccine adjuvants. Combinatorial synthesis and <em>in vivo</em> structure-activity studies were used to evaluate how properties of Polymer-TLR-7/8a conjugates (Poly-7/8a) influence innate immune activation in lymph nodes that drain the site of vaccine administration. The most striking finding was that particle formation by Poly-7/8a strongly enhances the magnitude and duration (&gt;14 days) of innate immune activation in lymph nodes by restricting agonist biodistribution and promoting uptake by dendritic cells. Particle-forming Poly-7/8a optimized for activity were found to induce only local innate immune activation (not systemic) and were effective for eliciting Th1-type CD4 and CD8 T cells that mediated protection against infectious challenge. Based on the importance of particle formation for activity of Poly-7/8a, thermo-responsive Poly-7/8a were developed that exist as single water-soluble macromolecules in solution but undergo temperature-driven particle formation <em>in vivo</em>. In conclusion, polymer carriers of TLR-7/8a represent a versatile and effective platform for modulating innate immune activity and warrant further investigation as a class of adjuvants for vaccines.</p>
spellingShingle Vaccinology
Advanced materials
Chemistry & allied sciences
Polymers Amino acid and peptide chemistry
Chemical biology
Materials Sciences
Supramolecular chemistry
Immunology
Nano-biotechnology
Nanomaterials
Lynn, G
Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title_full Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title_fullStr Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title_full_unstemmed Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title_short Polymer carriers of toll-like receptor-7/8 agonists as vaccine adjuvants
title_sort polymer carriers of toll like receptor 7 8 agonists as vaccine adjuvants
topic Vaccinology
Advanced materials
Chemistry & allied sciences
Polymers Amino acid and peptide chemistry
Chemical biology
Materials Sciences
Supramolecular chemistry
Immunology
Nano-biotechnology
Nanomaterials
work_keys_str_mv AT lynng polymercarriersoftolllikereceptor78agonistsasvaccineadjuvants